Metagenomic Sequence Market Revenue 2020, Industry Growth, Size, Segment, SWOT Analysis

Metagenomic Sequence Market Overview

Metagenomics sequencing, also known as environmental or community genomics is an approach that allows insight to be gained into community biodiversity and function. In the process of metagenomics sequencing, the DNA of the specified host microorganism is extracted and cloned directly from the microorganism using genetic analyses of DNA.

The function of metagenomic sequencing which is to sequence the genomes of untargeted cells in a community in order to elucidate community composition and function helps to understand the several types of cells in a community and what organisms are present in their physiology.

Research using the metagenomic sequencing taps into several fields due to the broad existence of large microbial communities. For instance; the study of soil microbiota has led to advances in understanding and treating plant pathogens. Whereas. In human gut microbiota, the use of metagenomics discovered how common antibiotic genes are in the gut bacteria.

Currently, the metagenomic sequencing market is growing pervasively. The dominant factors driving this growth include the rising awareness of genetic disorders, advanced technological platforms, and the availability of improved genomic tools. Moreover, the continually dropping prices of this process are escalating the market on the global platform, encouraging people to undergo the genetic tests.

Acknowledging the exponential growth this market is witnessing today, Market Research Future (MRFR), in its recently published study report asserts that the global metagenomic sequencing market will further garner enormous gains by 2023, registering approximately 6.5% CAGR throughout the forecast period (2017 – 2023).

The market demonstrates vast opportunities for service providers and companies with a great scope of expanding to enter the untapped regions by making these procedures affordable.

Additional factors fostering the growth of the market include the use of advanced bioinformatics tools, high throughput screening (HTS) methods, recovery of novel drugs, and the development of cost-effective technologies such as next-generation sequencing (NGS).

Moreover, increasing R&D activities to identify new antibiotics and enzymes, and improved bioinformatics support market growth, offering some attractive opportunities to the key market players.

Conversely, factors such as the rising concerns related to the standardization and accuracy of diagnostic testing alongside the lack of skilled professionals and knowledge are expected to impede the market growth over the forecast period. Nevertheless, public and private funding programs that are rapidly increasing are expected to support the market growth providing sufficient funds for R&D

Avail Free Sample @ https://www.marketresearchfuture.com/sample_request/5598

Metagenomic Sequence Market Segmentation:

MRFR report reveals the global metagenomic sequencing market as segmented by technology, application, and end-user.

Based on the technology, the global metagenomic sequencing market can be segmented into sequencing, bioinformatics, and others. Bioinformatics is gaining much traction owing to the need for sampling of the microbial communities that were not recorded while trying the traditional modules.

Based on the application, the global metagenomic sequencing market comprises gut microbe characterization, infectious disease diagnosis, environmental remediation, biotechnology, biofuel, ecology, agriculture, and others. Biofuel segment is gaining mileage as demand for reducing fossil fuel is getting stronger.

Based on the end-user, the metagenomic sequencing market can be segmented into hospitals, research institutes, specialized clinics, and others.

Metagenomic Sequence Market Regional Analysis:

Region-specific analysis of the global metagenomic sequencing market as conducted by the MRFR reveals the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).

The Americas has the advantage of having a robust infrastructure and substantial government and private spending capability. The region is including all the latest technologies available by investing substantially in the research and development sector.

The rising adoption of NGS procedure, along with low cost of the process, has been taken up by research laboratories which are driving the European market ahead. The market is also benefitting much from the joint ventures as a strategic move taken by companies.

The APAC market is expected to showcase the fastest growth rate during the forecast period. The region is benefitting majorly from two things, One, the rise of the developing economies who are spending substantially to develop their industrial scenario and the other is the market titans looking at the region as a prospect for market expansion. The region has affordable labor, and raw materials are quite easily available.

Meanwhile, the MEA region may manage only a meager growth due to the presence of several poor economies and lack of necessary infrastructure.

Metagenomic Sequence Market Competitive Landscape:

Major players in the global metagenomic sequencing market to make an impact are GATC Biotech AG (Germany), Biomatters Ltd. (New Zealand), Illumina Inc. (U.S.), Enterome Bioscience (France), Aperiomics, Inc. (U.S.), The Mitre Corporation (U.S.), F Hoffman-La Roche Ltd. (Switzerland), SciGenom Labs Pvt. Ltd. (India), Second Genome Therapeutics (U.S.), Freenome Inc. (U.S.), GenapSys, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), COSMOSID (U.S.), Pacific Biosciences (U.S.), Quest Diagnostics Incorporated (U.S.), Beijing Genomics Institute (China), Oxford Nanopore Technologies Inc. (UK), CLC Bio (Qiagen) (Denmark), DNAStar Inc. (U.S.), Agilent Technologies Inc. (U.S.), Macrogen Inc. (South Korea), Helicos BioSciences (U.S.), Knome Inc. (U.S.), and others.

Browse Complete Report with TOC @ https://www.marketresearchfuture.com/reports/metagenomic-sequencing-market-5598

In 2018, CoreBiome Founders revealed a report where the study shows the shallow-depth (0.5 million reads) and moderate-depth (1-2 million reads) shotgun sequencing can provide similar results like that of amplicon sequencing. The results based on the species-level taxonomic and functional data are quite promising.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com